RedHill Biopharma Ltd. Quarterly Research And Development Expense in USD from Q2 2017 to Q2 2022

Taxonomy & unit
ifrs-full: USD
Summary
RedHill Biopharma Ltd. annual/quarterly Research And Development Expense history and growth rate from Q2 2017 to Q2 2022.
  • RedHill Biopharma Ltd. Research And Development Expense for the quarter ending June 30, 2022 was $1.47M, a 85.7% decline year-over-year.
  • RedHill Biopharma Ltd. annual Research And Development Expense for 2023 was $3.53M, a 51.5% decline from 2022.
  • RedHill Biopharma Ltd. annual Research And Development Expense for 2022 was $7.28M, a 75.3% decline from 2021.
  • RedHill Biopharma Ltd. annual Research And Development Expense for 2021 was $29.5M, a 78.9% increase from 2020.
Research And Development Expense, Quarterly (USD)
Research And Development Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2022 $1.47M -$8.86M -85.7% Apr 1, 2022 Jun 30, 2022 6-K 2022-11-07
Q2 2021 $10.3M +$7.11M +221% Apr 1, 2021 Jun 30, 2021 6-K 2022-11-07
Q2 2020 $3.21M -$3.76M -53.9% Apr 1, 2020 Jun 30, 2020 6-K 2021-08-26
Q2 2019 $6.97M +$928K +15.4% Apr 1, 2019 Jun 30, 2019 6-K 2020-08-13
Q2 2018 $6.04M -$2.39M -28.3% Apr 1, 2018 Jun 30, 2018 6-K 2019-07-23
Q2 2017 $8.43M Apr 1, 2017 Jun 30, 2017 6-K 2018-08-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.